{
  "conversation_id": "a6579bfa0acc3910cbb8a256d0a4a890cbd851c667b599271f8c87cd453a9f0c",
  "chat_history": "{\n  \"messages\": [\n    {\n      \"metadata\": {},\n      \"content_type\": \"message\",\n      \"role\": \"user\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Given the presence of a KRAS p.G12C mutation, what are the potential benefits and risks of transitioning to KRAS-directed treatment with adagrasib? How might this change the patient's prognosis?\"\n        }\n      ]\n    },\n    {\n      \"ai_model_id\": \"gpt-5-mini\",\n      \"metadata\": {\n        \"logprobs\": null,\n        \"id\": \"chatcmpl-CBcuXJr8L4vXt4SKNM3Hfmx67TaqX\",\n        \"created\": 1756887217,\n        \"system_fingerprint\": null,\n        \"usage\": {\n          \"prompt_tokens\": 1256,\n          \"completion_tokens\": 1898\n        }\n      },\n      \"content_type\": \"message\",\n      \"role\": \"assistant\",\n      \"name\": \"Orchestrator\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Checklist \u2014 my planned moderation steps\\n- Clarify whether you want a general evidence summary or a patient-specific assessment.\\n- Gather necessary patient details (or a valid patient ID) to enable patient-specific inputs.\\n- Ask PatientStatus what exact data it needs, then request that info from you.\\n- Query MedicalResearch for evidence on adagrasib (benefits, risks, resistance) and ClinicalGuidelines for guideline context (without giving treatment recommendations).\\n- Share each agent's input back to you, summarize progress, and ask for confirmation or next steps.\\n\\nPlanned participants and sequence\\n1) PatientStatus \u2014 to synthesize current patient status (requires patient details). PatientStatus, please list what you need below. Each agent must conclude with: \\\"back to you: Orchestrator\\\".\\n2) MedicalResearch \u2014 to summarize clinical trial evidence for adagrasib (efficacy, common/serious adverse events, resistance mechanisms).\\n3) ClinicalGuidelines \u2014 to provide guideline-contextual information (indications/approval status and guideline positioning) \u2014 note: no clinical recommendations or personalized treatment plans.\\n4) ClinicalTrials (optional if you want alternatives) \u2014 to list relevant trials for KRAS G12C patients.\\n5) ReportCreation (optional) \u2014 to assemble a tumor-board style document if desired.\\n\\nUser \u2014 I need a clarification to proceed\\n- Do you want a general evidence-based summary about adagrasib for KRAS p.G12C (non\u2013patient-specific), or do you want an assessment of how switching to adagrasib might affect a specific patient's prognosis?\\n- If you want a patient-specific assessment, please either:\\n  a) Provide a valid patient ID (string) so PatientHistory can retrieve the timeline (Note: PatientHistory requires a patient ID string), or\\n  b) Provide the following patient details directly:\\n     - Primary cancer site and histology (e.g., non\u2013small cell lung cancer, adenocarcinoma)\\n     - Current stage and sites of metastasis (if any)\\n     - Age\\n     - ECOG performance status\\n     - Prior systemic therapies and lines of treatment\\n     - Biomarkers besides KRAS p.G12C (PD-L1, EGFR, ALK, MET, etc.)\\n     - Significant comorbidities (hepatic/renal dysfunction, interstitial lung disease, cardiac disease)\\n     - Concomitant medications (especially strong CYP3A inhibitors/inducers)\\n     - Presence of symptomatic brain metastases\\n\\nPatientStatus, please proceed\\n- PatientStatus, what specific data elements do you require (and in what format) to provide a concise current-status summary usable by the other agents? Please respond listing the fields and expected formats. Each agent must end with: \\\"back to you: Orchestrator\\\"\\n\\nNext steps after your reply\\n- If you choose general evidence summary: I will call MedicalResearch and ClinicalGuidelines to provide the benefits, risks, likely impact on prognosis (based on published data and guideline context), and common resistance mechanisms.\\n- If you provide patient-specific data or a patient ID: I will first have PatientStatus summarize the current status, then route that to MedicalResearch and ClinicalGuidelines for personalized-context evidence and guideline framing.\\n\\nPlease confirm which path you prefer and provide either the patient ID (string) or the requested patient details.\"\n        }\n      ],\n      \"finish_reason\": \"stop\"\n    }\n  ]\n}",
  "patient_id": null,
  "patient_data": [],
  "display_blob_urls": [],
  "display_clinical_trials": [],
  "output_data": [],
  "healthcare_agents": {}
}